🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Belgium / NCT06804369
Active, not recruiting Observational

Benchmarking and Change Mechanisms in Personality Disorder Treatment

NCT06804369 · tracked via the Priya Life Science Belgium tracker
Sponsor
Phase
Observational
Started
2023-04-17
Last updated
2025-12-10

Condition(s) studied

Personality Disorders

Investigational drug(s) / intervention(s)

Intensive psychodynamic therapy (PDT)

Intensive psychodynamic therapy (PDT): The KLIPP treatment unit (UPC KU Leuven, campus Kortenberg) provides intensive psychodynamic treatment (PDT) for patients with different types of PDs. There are three different programs that differ in treatment intensity: (1) inpatient treatment program (5 days a week), (2) day treatment program (4 days a week), and (3) a part-time outpatient treatment program of two half days per week. Patients attend one of these programs and stay in the program for at least 6 months (with an average duration of 8 months). The programs include individual and group psychodynamic psychotherapy as well as art, music and psychomotor therapy.

Study summary

Personality disorders (PDs) are severe mental disorders characterized by pathological personality traits as well as problems in identity and interpersonal relationships (American Psychiatric Association, 2013). Several effective psychotherapies for PDs have been developed in the past decades, however, two important questions regarding PD treatment have not been sufficiently addressed: (1) how effective are PD treatments outside of the controlled settings of randomized controlled trials (RCTs); (2) are the effects of PDT clinically meaningful; and (3) what are the core processes that produce change in PD treatment? The present observational study aims to address these research gaps by (1) comparing the effects of intensive psychodynamic therapy (PDT) for PDs in a naturalistic setting to benchmarks found in RCTs; (2) analyzing which proportion of patients achieves clinically meaningful change and (3) investigating whether outcomes in intensive PDT are associated with a number of theoretically expected mechanisms of change.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Individuals (male, female, non-binary or other) older than 18 years 2. Meeting criteria for personality disorder as assessed by a psychiatrist and confirmed with the PID-5 and LFPS self-report scales 3. Sufficient mastery of the Dutch language to follow treatment and complete questionnaires 4. Agreeing to participate in the study following informed consent procedure Exclusion Criteria: 1. Substance abuse that would interfere with the ability to adhere to the treatment 2. Acute psychotic symptoms as assessed by a psychiatrist

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Psychiatric Center KU Leuven Kortenberg Vlaams-Brabant

More KU Leuven trials in Belgium

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06804369 on ClinicalTrials.gov ↗ ← All trials in Belgium